Damage From Binge-Drinking in Pregnancy Worsens With Age

WEDNESDAY, July 21 (HealthDay News) -- Older women who binge-drink when pregnant are at higher risk for having children with permanent alcohol-related brain damage, new research finds.

Health Tip: Treating Cradle Cap

(HealthDay News) -- Red, scaly skin on a new baby's scalp could be seborrheic dermatitis, also called cradle cap.

Health Tip: Signs That You May Have Hand Arthritis

(HealthDay News) -- Arthritis, the medical term for joint inflammation, commonly affects the relatively small joints of the hands.

People With Drinking Problems May Turn to Clergy for Help

WEDNESDAY, July 21 (HealthDay News) -- Many people afflicted with alcohol abuse problems turn to their clergy for counsel, new research reveals.

Florida's Minorities See Unusual Melanoma Patterns

WEDNESDAY, July 21 (HealthDay News) -- Melanoma trends among minority groups in Florida, the Sunshine State, are different than national trends, a new study finds.

Meditation Appears to Boost Attention Span

WEDNESDAY, July 21 (HealthDay News) -- In research inspired by Buddhist monks, a new study has found that meditation can seemingly help increase a person's attention span.

Prenatal Vitamin Levels a Concern After Weight Loss Surgery

WEDNESDAY, July 21 (HealthDay News) -- Women who have weight loss surgery may put their future babies at risk caused by vitamin deficiencies, say Australian researchers.

PTSD Peaks at Different Ages in Men, Women

WEDNESDAY, July 21 (HealthDay News) -- Women are most vulnerable to post-traumatic stress disorder (PTSD) between ages 51 and 55, while men are more prone to the condition from ages 41 to 45, a new study finds.

Risky Behavior, Drug Use Among Some Gay Men Linked to Childhood Abuse

WEDNESDAY, July 21 (HealthDay News) -- Gay and bisexual men who were victims of sexual abuse and social shaming as children are more likely to have psychosocial health problems that could put them at greater risk for HIV infection, a new study suggests.

Procedure Rejuvenates Aging Arteries in Pigs

WEDNESDAY, July 21 (HealthDay News) -- A two-step procedure that uses nanoparticles to first scrub plaque out of arteries and then inserts stem cells to promote healing of those arteries may one day help individuals with atherosclerosis, new research suggests.

Moderate Caffeine Intake Safe During Pregnancy, Experts Say

WEDNESDAY, July 21 (HealthDay News) -- Women can drink a cup of coffee or one soft drink a day during pregnancy and not worry that it might put them at risk of miscarriage or preterm birth, according to new guidelines released by the American College of Obstetricians and Gynecologists.

Vaginal Delivery May Be OK After C-Section

WEDNESDAY, July 21 (HealthDay News) -- Many women who've had a Cesarean section may be candidates for vaginal birth in future pregnancies, say new guidelines from the American College of Obstetricians and Gynecologists.

Health Highlights: July 21, 2010

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Not Every ACL Tear Needs Early Surgery, Study Suggests

WEDNESDAY, July 21 (HealthDay News) -- Tears to the anterior cruciate ligament (ACL) of the knee are a relatively common and debilitating sports injury, typically leading to surgical repair.

Study Points to Molecular Origins of Celiac Disease

WEDNESDAY, July 21 (HealthDay News) -- Scientists believe they've identified the molecular triggers of celiac disease, a finding they say could lead to the first drugs to tame the chronic, painful gut disorder.

Clinical Trials Update: July 21, 2010

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Gene Therapy Shows Promise With 'Bubble Boy' Disease

WEDNESDAY, July 21 (HealthDay News) -- Eight of nine male infants born with so-called "Bubble Boy" disease were still alive and well nine years after they underwent gene therapy, French researchers report.

FDA Puts Partial Hold on Avandia Safety Study

WEDNESDAY, July 21 (HealthDay News) -- No new patients will be permitted to enroll in a safety study of the controversial diabetes drug Avandia until further notice, the U.S. Food and Drug Administration announced Wednesday.